DESVENLAFAXINE
These highlights do not include all the information needed to use DESVENLAFAXINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DESVENLAFAXINE EXTENDED-RELEASE TABLETS. DESVENLAFAXINE Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
ff837eb1-24c3-4c63-9b4b-c6b5935a9b47
HUMAN PRESCRIPTION DRUG LABEL
Dec 19, 2023
Advagen Pharma Ltd
DUNS: 051627256
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
DESVENLAFAXINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
DESVENLAFAXINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
DESVENLAFAXINE
Product Details
FDA regulatory identification and product classification information